The 2024 FDA Diversity Guidance Update: What does it mean for patients, sites, sponsors and CROs
The FDA's June 2024 draft diversity guidance builds on their 2022 draft guidance to make clinical trials even more inclusive by going beyond race and ethnicity to include other demographic characteristics.
This video brings together a panel of experienced clinical research experts to share their perspectives on what this updated FDA Draft Diversity Guidance means for sponsors, sites, CROs and, most importantly, study participants. They’ll discuss what is new to the 2024 guidance, how sponsors, sites and CROs will operationalize it, how this guidance impacts global clinical trials, and more.
Related Insights
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Removing barriers through pragmatic clinical trials
Oct 12, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Article
3 ways to incorporate DE&I in your communications strategy
Sep 29, 2021
Video
The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?
Feb 1, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021
Related Insights
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Blog
Removing barriers through pragmatic clinical trials
Oct 12, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Blog
A patient-centric approach to managing clinical trial complexity
Jul 13, 2021
Article
3 ways to incorporate DE&I in your communications strategy
Sep 29, 2021
Video
The FDAs Race and Ethnic Diversity Plan Guidance: How prepared is your organization?
Feb 1, 2023
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Report
New Medicines, Novel Insights: Achieving patient-guided drug development
Oct 30, 2023
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Article
Decentralized clinical trials - A more patient-centric approach
May 10, 2021